Cellebrite DI Ltd. (CLBT) Tops Q3 EPS by 6c; raises guidance

Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q3 EPS of $0.09, $0.06 better than the analyst estimate of $0.03. Revenue for the quarter came in at $84.2 million versus the consensus estimate of $82.13 million.

GUIDANCE

Company Increases 2023 ARR and Adjusted EBITDA Outlook, and Raises Mid-Point for Expected 2023 Revenue Range: 2023 Revenue of $315 million - $320 million; December 2023 ARR of $310 million - $315 million; 2023 Adjusted EBITDA of $50 million - $55 million.

For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• William Blair starts AMD at Market Perform, sees balanced risk-reward
• Bernstein: 'Case studies from Microchip and other Semiconductor LTAs - What's different this time?'